<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="975">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04725097</url>
  </required_header>
  <id_info>
    <org_study_id>20-011415</org_study_id>
    <nct_id>NCT04725097</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection</brief_title>
  <official_title>Rapid Throughput Screening for Human COVID-19 Infection: A ECG Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the ability of an artificial intelligence&#xD;
      smartphone-enabled point of care ECG to detect COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2020</start_date>
  <completion_date type="Anticipated">August 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COVID 19 Detection</measure>
    <time_frame>One time screening within 4 hours of PCR test</time_frame>
    <description>Determine the safety and feasibility of the POC AI-ECG's ability to detect active SARS-Cov-2 infection in humans.</description>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Detection of COVID-19 when compared to a PCR test in asymptomatic patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult males and females age 18 or greater.&#xD;
&#xD;
          -  Undergoing COVID-19 testing by PCR.&#xD;
&#xD;
          -  Willing and able to provide informed consent.&#xD;
&#xD;
          -  Pregnant females (minimal risk study, no risk from ECG).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Unwilling or unable to provide informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elie F Berbari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>J Dugan</last_name>
    <phone>507-538-1125</phone>
    <email>dugan.jennifer@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J Dugan</last_name>
      <email>dugan.jennifer@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Paul A Friedman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elie Berbari, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sri Jayadeva</name>
      <address>
        <city>Bengaluru</city>
        <state>Karnataka</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deepak Padmanabhan, M.D.</last_name>
      <email>deepak.padmanabhan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jayaprakash Shenthar, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>C.N. Manjunath, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gregorio Mara√±on Hospital</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felipe Atienza Fernandez, M.D.</last_name>
      <email>felipe.atienza@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Francisco Fdez-Aviles, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imperial College</name>
      <address>
        <city>London</city>
        <state>England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>N. Peters, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>M Kelshiker, M.D.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>India</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Elie F. Berbari</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

